Tovorafenib Terminated Phase 1 Trials for Melanoma Other

IndicationsStatusPurposePhase
TerminatedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT02723006Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma